Related Experiment Video

Updated: May 30, 2026

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
10:38

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

Retraction Note: Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular

    Angiogenesis
    |July 21, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
    06:51

    Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

    Published on: December 9, 2022

    Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
    06:06

    Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

    Published on: March 9, 2019

    Related Experiment Videos

    Last Updated: May 30, 2026

    Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
    10:38

    Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

    Published on: January 15, 2018

    Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
    06:51

    Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

    Published on: December 9, 2022

    Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
    06:06

    Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

    Published on: March 9, 2019

    Related Concept Videos

    Regulation of Angiogenesis and Blood Supply01:24

    Regulation of Angiogenesis and Blood Supply

    Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
    Mechanism of Angiogenesis01:10

    Mechanism of Angiogenesis

    Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

    Articles linked to this work by shared authors, journal, and citation graph.

    Regulation of PDGF-BB signaling in placental pericytes by soluble PDGFRβ isoforms: implications for fetoplacental vascular development.

    Angiogenesis·2026

    Intimal hyperplasia and adventitial angiogenesis originating from veins are vascular remodelling responses in large vessels after major lower extremity trauma induced ischemia.

    Angiogenesis·2026

    Ocular gene therapy targeting retinal angiogenesis and vascular leakage: translational and clinical evidence from a systematic review and meta-analysis.

    Angiogenesis·2026

    Evaluating the endothelial glycocalyx from bench to bedside: a translational framework for microvascular assessment.

    Angiogenesis·2026

    CXCL12/CXCR4 signaling governs ischemic neurovascular pathophysiology and repair: a multidimensional contextual analysis.

    Angiogenesis·2026

    Pathogenesis and molecular mechanisms of mutant TIE2-driven venous malformation.

    Angiogenesis·2026

    Tolerance of methotrexate co-administered with pegloticase in patients with uncontrolled gout: overview of the findings from the mirror RCT.

    Expert opinion on drug safety·2026

    The Hidden Cost of QTc Assessment: A Quantitative Weight of Evidence Framework to Eliminate Structural False Positives and Restore the Lost Opportunity Cost of Abandoned Medicines.

    Clinical pharmacology and therapeutics·2026

    Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.

    Reviews on recent clinical trials·2026

    A collaborative study evaluating the detection of virus-infected cells by transcriptomic high-throughput sequencing.

    Microbiology spectrum·2026

    Correction to "Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026".

    Pregnancy (Hoboken, N.J.)·2026

    When meta-analyses mislead: Promises and pitfalls in teratology counselling.

    British journal of clinical pharmacology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us